Business Context and Reporting Period
Passage BIO, Inc. (PASG) filed a Form 8-K on March 4, 2026, reporting the termination of a material definitive agreement. The company is an emerging growth company incorporated in Delaware with principal executive offices in Philadelphia, PA.
Key Financial Metrics
- Termination Fee: Approximately $4.8 million payable to Hopewell Campus Owner LLC.
- Accrued Rent: Payment required for rent accrued through February 14, 2026.
- Liquidity Outlook: Management expects cash and cash equivalents to fund operations through the first quarter of 2027.
- Revenue, Profit, Margins, Debt: The filing text does not provide a clear value for these metrics.
Material Changes
The company terminated the "Hopewell Lease," a 15-year agreement for approximately 62,000 square feet of laboratory space that commenced in March 2021. This action follows a restructuring in January 2025, after which the company ceased all operations at the Hopewell facilities.
Outlook, Risks, and Management Commentary
Management maintains the expectation that current capital resources will sustain operations into Q1 2027. However, the filing explicitly states that this estimate is based on assumptions that may prove incorrect. The company warns that operating plans may change due to unknown factors, potentially leading to the depletion of capital resources sooner than expected.
Investor Verification Checklist
- Verify the total cash outflow required for the $4.8 million termination fee plus accrued rent.
- Confirm current cash and cash equivalent balances to validate the runway through Q1 2027.
- Review the January 2025 restructuring details to understand the full scope of operational cessation.
- Assess the impact of the facility closure on future R&D capabilities or potential asset sales.